These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 10803013)

  • 1. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene--a prevalence study].
    Röhrig S; Grob PJ
    Schweiz Med Wochenschr; 1990 Apr; 120(17):621-9. PubMed ID: 2160123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of chronic viral hepatitis in drug abusers].
    Osztrogonácz H; Gerevich J; Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 2000 Apr; 141(14):715-8. PubMed ID: 10803013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection: pathogenesis, diagnosis and treatment.
    Pár A; Gervain J; Gógl A
    Scand J Gastroenterol Suppl; 1998; 228():107-14. PubMed ID: 9867120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic disease in injection drug users.
    Lemberg BD; Shaw-Stiffel TA
    Infect Dis Clin North Am; 2002 Sep; 16(3):667-79. PubMed ID: 12371121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity and alcoholic and viral chronic liver disease].
    Doffoël M
    Gastroenterol Clin Biol; 2004 Mar; 28(3):268-71. PubMed ID: 15094676
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges and issues in managing hepatitis C.
    Maghlaoui A
    Nurs Times; 2012 Aug 7-20; 108(32-33):18-20. PubMed ID: 22930911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of chronic hepatitis B virus infection in the Northern Territory.
    Wood N; Backhouse J; Gidding HF; Gilbert GL; Lum G; McIntyre PB
    Commun Dis Intell Q Rep; 2005; 29(3):289-90. PubMed ID: 16220866
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.